CNO (CNO)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$8.32B
EV / Sales1.79
EV / EBITDA11.33
EV / Operating Cash Flow12.09
EV / Free Cash Flow12.09

Return Metrics (TTM)

Return on Equity (ROE)10.89%
Return on Assets (ROA)0.72%
Return on Invested Capital (ROIC)0.59%
Return on Capital Employed (ROCE)0.75%

Yield Metrics

Earnings Yield5.42%
Free Cash Flow Yield13.37%

Balance Sheet Strength

Net Debt / EBITDA4.32
Current Ratio0.73
Working Capital-$5.17B
Tangible Asset Value-$82.40M
Net Current Asset Value-$22.41B

Working Capital Efficiency

Days Sales Outstanding364.81
Days Payables Outstanding0.00
Operating Cycle (Days)364.81
Cash Conversion Cycle364.81

Capital Allocation

CapEx / Revenue0.00%
CapEx / Operating Cash Flow0.00%
R&D / Revenue0.00%
SG&A / Revenue0.00%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin44.79%
Operating Margin6.54%
Net Profit Margin5.11%

Solvency

Debt / Equity1.54
Quick Ratio0.71
Cash Ratio0.05

Per Share

Revenue / Share$45.90
FCF / Share$6.91
PE Ratio18.07